Answers are grounded in this paper and cite their sources.
In vitro radiobiological experiments using ultra-high dose rate (UHDR) irradiation were performed already during the 1960s to 1980s, with several promising studies demonstrating normal tissue sparing [1–5]. In the last decade, UHDR irradiation has again gained significant momentum within the radiotherapy community. UHDR irradiation has demonstrated increased normal tissue tolerance across organ systems and endpoints, using diverse delivery techniques. Intriguingly, the sparing effect appears to preferentially benefit normal tissue, suggesting a widening of the therapeutic window - a phenomenon now widely referred to as the FLASH effect [6–9].
No takes yet. Share an insight, caveat, or question.
Adrian et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: